A B S T R A C T An elevated concentration of lipoprotein (a) [Lp(a)] in the serum has been considered a risk factor for coronary heart disease by various investigators. In the present study, the turnover of Lp(a) was investigated in nine individuals with serum Lp(a) levels ranging from 1 to 68 mg/100 ml. After intravenous injection of radioiodinated Lp(a), the radioactivity time-curve of the serum and the specific activitity time-curves of the isolated Lp(a) and Lp(a) apolipoproteins were measured for 14 d. More than 97% of the label was found in the protein moiety of Lp(a). During the entire study period, the serum radioactivity remained with Lp(a), only insignificant amounts of radioactivity were detectable in other lipoprotein fractions. The serum radioactivity timecurves and the specific activity time-curves of the isolated Lp(a) and Lp(a) apolipoproteins were identical.
INTRODUCTION
When the lipoprotein (a) [Lp(a)]' was first described (1) , it was considered a genetic variant of low density Received for publication 15 Atuguist 1979 and in revised form 11 December 1979. 1 Abbreviations uised in this paiper: FCR, fractional catabolic rate; HDL, high density lipoprotein; LDL, low density lipoprotein; Lp(a), lipoprotein (a); VLDL, very low density lipoprotein.
lipoprotein (LDL). Other studies, however, have demonstrated that Lp(a) is a separate lipoprotein, although it exhibits some physicochemical and immunological properties that are similar to those of LDL. The lipid composition of these two lipoproteins, as determined by several investigators (2) (3) (4) , is nearly identical. On the other hand, Lp(a) shows a severalfold higher content of hexose, hexosamine, and sialic acid than LDL (5) . This may explain why Lp(a) migrates faster than LDL on agarose gel or cellulose acetate and, therefore, forms a separate band between ,B-and pre-,8-lipoproteins, which was named "prepl," band (6) (7) (8) . The main apolipoprotein of Lp(a) has been found to be identical with apolipoprotein B of LDL (5, 9) . Lp(a), however, contains an additional, specific Lp(a) antigen, which is dissociable from apolipoprotein B by several agents (5, 10) . In contrast to apolipoprotein B, the specific Lp(a) antigen is soluble in 6 M urea (11) . By ultracentrifugation Lp(a) is found in the fraction of density 1.055-1.110 g/ml (11) , which is somewhat higher than the density of LDL and overlaps that of LDL and high density lipoproteins (HDL).
It is well documented that Lp(a) is present in the serum of all individuals with apolipoprotein B, although in different individuals its serum level may vary to a considerable degree (12, 13) . Lp(a) has gained extensive clinical interest since a relationship between the concentration of Lp(a) in the serum and the occurrence of coronary heart disease has been postuilated by several investigators (6, 7, 13, 14) . Lp(a) has also been demonstrated by immunohistochemical methods in the intima of human arteries (15) .
Although Lp(a) might play an important role in the development of atherosclerotic vascular lesions, only scarce information is available about the metabolism of this lipoprotein. In a previous study the half-life of radiomethylated Lp(a) has been determined (16) .
It has been shown recently that Lp(a) is not a metabolic product of other apolipoprotein B-containing lipoproteins (17) . Therefore it has been suggested that Lp(a) is synthesized as a separate lipoprotein. No information, however, exists about the regulation of the serum concentration and the catabolic pathway of Lp(a).
METHODS
Sutbjects. The clinical data of the subjects are given in Table I . None of them revealed thyroid, renal, or hepatic dysfunction or hyperglycemia. All individuals were checked for Lp(a) by immunodiffusion with specific antisera to Lp(a) (see below). All subjects were "Lp(a)-positive" except subject No. 1. In this individual no Lp(a) could be detected by immunodiffusion and no measurable Lp(a) concentration was found using Laurell's one-dimensional immunoelectrophoresis (see below). All individuals were hospitalized during the investigation. They were kept on a "normal" hospital diet containing 45-50% of total calories as carbohydrates, 30-35% fat, and 15-20% protein. None of' them received any treatment (except thiazide diuretics) known to influence lipid metabolism. Body weight and the serum concentration of Lp(a), total cholesterol, and triglyceride were constant throughout the study (Table I) . Potassium iodide (3 x 60 mg daily) was administered to each individual beginning 3 d before the study and continuing throughout the entire experiment. Informed consent to the study was obtained from each subject.
Separation and iodination of Lp(a). Lp(a) was isolated according to the method of Ehnholm et al. (18) . After an overnight fast, plasma was obtained by plasmapheresis using citrate-dextrose as anticoagulant and dialysed against 0.15 M NaCl containing Na2EDTA (1 mg/ml) and NaN3 (1 mg/ml). The plasma was then brought to a solution density of 1.055 g/ml by addition of solid NaCl and centrifuged at 42,000 rpm for 22 h. The densities of the sera were measured at 15'C with a calculating digital density meter (Anton Paar K.G., Graz, Austria). All ultracentrifugal procedures were performed in a Beckman L5-50 centrifuge with a Ti 50.2 rotor at 15'C (Beckman Instruments, Inc., Fullerton, Calif.). The top fraction was removed by tube slicing, the lower f'raction was brought to a density of 1.110 g/ml by addition of solid NaCl and then centrifuiged at 44.000 rpm for 22 h. The top fraction, which contained the lipoproteins with densities of 1.055-1.1 10 g/ml, was concentrated to a volume of'abouit 4 ml by dialysis against a 30% solution of polyethyleneglycol (mol wt, 20.000) containing Na2EDTA (1 mg/ml) and NaN3 (1 mg/ml). Lp(a) was then separated from other lipoproteins by filtration on an agarose column (0.9 x 100 cm) using Bio Gel A-Sm (Bio-Rad Laboratories, Richmond, Calif.).
Elution of the lipoproteins was carried ouit at room temperature with 0.15 M NaCl containing Na2EDTA (1 mg/ml) and NaN3 (1 mg/ml), pH adjusted to 8.5 by additioni of NH40H.
The elution profile is shown in Fig. 1 . The peaks were identified by immunodifftusion uising monospecific antisera (16, 17, 19 Chlaracterizationt of the labeled Lp(a). Labeled Lp(a) showed the same electrophoretic mobility on agarose gel and identical immunoreactive behavior as unlabeled Lp(a). When labeled and unlabeled Lp(a) were mixed and applied to an agarose column (Bio-Gel A-5m), the labeled Lp(a) eluted in the same fraction as the unlabeled Lp(a). 0.5-3% of the radioactivity in Lp(a) was found in the lipid moiety after extraction xvith chloroform:methanol (2:1) (22). 14-17% of the radioactivity in Lp(a) was fouind in the "soluble" and 80-85% in the "insoluble" apolipoproteins (see below).
Sttudy protocol. Labeled Lp(a) was sterilized by passage through a Millipore filter (0.45 nm; Millipore Corp., Bedford, Mlass.) before the injection. After an overnight fast, 50-70 ,tCi labeled Lp(a) was injected intravenously. Autologouis Lp(a) %vas inijected in subjects 3-6 anid 9. Subjects 1 and 2 received lal)eled Lp(a), wlhich was obtained from stubject 5, and subjects 7 and 8 received labeled Lp(a) from subject 9. Venous blood was drawn 10 min after the injection of the labeled Lp(a) and at various intervals during the 1st d and then everxy morning for up to 14 d. Two subjects were studied for 21 d. In these samples the radioactivity ofthe serum was measured. In subjects 3-6, 50 ml of blood was obtained 10 min, 6 h, and 24 h after the injection of labeled Lp(a), and then at different intervals throughouit the study, as shown in Fig. 3 . In these samiples, Lp(a), very low density lipoproteins (VLDL) and LDL were isolated and the radioactivity in these lipoproteins and in the fraction wvith a density > 1.110 g/ml was estimanated as follows: Serum was brought to a density of 1.055 g/ml by addition of solid NaCl and centrifuged for 22 h at 42,000 rpm.
The top fraction, wlhich contained1 VLDL and the bulk of LDL, was collected by ttube slicing, dialyzed against saline with a density of 1.006 g/ml, and then centrifuiged for 20 h at 42,000 rpm. The top fraction, was removed by slicing the ttube. From the bottom fractioin LDL wvas purified from contaminating Lp(a) by gel filtratioin on Bio-Gel A-Sm as described above.
The fractions containing VLDL, the purified LDL, the pturified HDL, which eltuted from the agarose columlln (Fig. 1) , and the density > 1.110 g/ml fraction were checked for radioactivity. Lp(a) was isolated and purified by ultracentrifugation and gel filtration as described above. In the purified Lp(a), protein content and radioactivity were measured. In addition, part of the purified Lp(a) was dialyzed against distilled water, lyophilized, and the lipids removed with diethylether:ethanol (1:3, vol/vol). From the resultant apolipoproteins, the soluble apolipoproteins were obtained by extraction with 6 M urea. The insoluble apolipoproteins were washed several times with 6 M urea. Removal of soluble apolipoproteins was considered complete when no radioactivity could be detected in the urea solution. The remaining insoluble apolipoproteins were solubilized by addition of sodium dodecyl sulfate. The protein content and the radioactivity in both the soluble and insoluble apolipoproteins were measured to obtain the specific activity. The mean ratio of the specific activities in soluble and insoluble apolipoproteins was 2:3 and remained constant throughout the study.
In three subjects (Nos. 7-9) 24-h urine specimens were collected for calculation of the fractional catabolic rate of Lp(a) from the urinary radioactivity excretion. KI, NaHSO3, and NaOH was added to the urine samples as a preservative (23) .
Chemical and inmminological analysis. Protein concentrations were measured according to Lowry et al. (24) , total cholesterol by the Lieberman Burchard kit from Boehringer Mannheim GmbH, Mlannheimii, WVest Germanv, and triglvcerides according to Eggstein andl Kreutz (25) . Agarose electroplhoresis was carried out in 1% agarose gel using 0.05 M barbital buffer, pH 8.2. Immunodiffusion was performed in 1% agarose using monospecific antisera (19) . Quantitation of serum Lp(a) was carried out by Laurell's electroimmunoassay (rocket electrophoresis) (26) on glass plates (7 x 7 cm) in 1% agarose gels, 0.05 M barbital buffer, pH 8.2. The antibody was monospecific for the Lp(a) antigen and identical with the specimeni described earlier (16, 17, 19) ; it gave no crossreactivity with apo B or any other apolipoprotein of the A-F class. 0.05 or 0.1 ml of antiserum was used per 6 ml of agarose and per plate. Each plate was used for 14 analyses and contained three highly purified Lp(a) standards of different concentrations as well as 1-3 reference Lp(a)-positive sera, which had been standardized and kept at 4°C for <1 mo. The purified Lp(a) standard was prepared as described above and was homogenous according to the following criteria: single band in agarose gel electrophoresis, no reaction with antibodies other than anti-Lp(a) and antiLp B, chemical composition characteristic for Lp(a) (11, 16, 17) . The concentration of the standard was measuired gravimnetrically by determination of the residtual weight after equilibration dialysis (coefficient of variation was < 1%). Electrophoresis was carried out at a field strength of 5 V/cm for 3 h at 15°C in 0.05 M1 barbital buffer, pH 8.2. The plates were rinsed after electrophoresis in 0.15 M saline for 2-4 h, dryed, and stained with Coomassie Blue R 250. The evaluiation of the Lp(a) concentrations was performed by comi)ariing the rocket area (height times width at half height) of the samples with that of highly purified standards. The relationiship between the rocket area (mm2) and protein concentrationi was linear from 5-25 mg Lp(a)/100 ml in the low antibody containing gels and from 20-60 mg Lp(a)/100 ml in the high antibody containing gels. Samples of higher concentrations were diltuted accordingly. The electroimmiunoassay worked with a day-to-day coefficient of variation of <5%.
Calcilatiotns. The fractioni of the injected dose of radioactivity remaining in the plasma wvas plotted semilogarithmically against time (Fig. 2) . The fractional catabolic rate (FCR = fraction of intravasctular Lp(a) catabolized per day) was calctulate(d accordinig to the method described by Matthews the first and second exponential with the vertical axis and b,, b2 = slopes of the first and second exponential (Fig. 2) . The proportion of the total pool of Lp(a) that was in the intravascular space was calctulated using the formtula (27) Edelman's formula (28) . FCR was also calculated as the ratio of the daily urinary excretion of radioactivity to the total amount of radioactivity in the plasma (29) . Statistical calculations were performed using standard methods (30) .
RESULTS
Throughout the study, >96% of the total radioactivity in the serum remained with Lp(a). Less than 0.05% ofthe serum radioactivity was found in VLDL. In LDL, HDL, and in the salt volume eluting from the column, only traces of radioactivity were detectable after purification on Bio-Gel A-5m. In the unpurified density fraction > 1.110 g/ml, a total amount of <3% of the serum radioactivity was found. Presumably, this was due to contamination with labeled Lp(a), in that the radioactivity in purified HDL was negligible. Under the assuimption that the labeled apolipoprotein has not been altered by iodination, these findings seem to indicate that no conversion of serum Lp(a) to other sertum lipoproteins or exchange of apolipoproteins between Lp(a) and other lipoproteins occurred.
In four subjects the specific activities of the isolated intact Lp(a) molecule and of the soluble and the insoluble apolipoproteins were determined at different times of the study as shown in Fig. 3 . These values are expressed as fraction of the specific activities at 10 min after the injection of labeled Lp(a). The valtues obtained for the whole Lp(a) molecule, the soluible and the insoluble apolipoproteins were compared with the corresponding values of the serum radioactivity decay cturve. The mean difference between the values of the intact Lp(a) and the corresponding values of the serum radioactivity decay curve was + 0.3+4.8% (mean ± 1 SD), between the soltuble apolipoproteins and the serum radioactivity was +0.5±7.5%, and between the insoluble apolipoproteins and the sertum radioactivity was -3.0+6.5%. This shows that the decay of the specific activity of the whole Lp(a) molecule and of the individual apolipoproteins was practically identical with the decay of the serum radioactivity. The percentage of radioactivity in the lipid moiety of the Lp(a) molecule showed some decline during the first days of the experiment, but was too low to influence the calculation of the kinetic parameters at any time of the study.
Therefore, it was permissible to calculate the kinetic parameters of the Lp(a) turnover from the serum radioactivity-time curves. The concentration of Lp(a) in the serum was determined by immunoelectrophoresis repeatedly from the beginning uintil the end of the study and showed little variation as indicated in Table  I . In subjects 3-6, the serum level of Lp(a) apolipoprotein could also be calculated from the radioactivity of the serum and the specific activity of the isolated Lp(a), since >96% of the radioactivity in the serumii was associated with the protein moiety of Lp(a). Also from this calculation, a constant Lp(a) concentration was found in each case. The constancy of the Lp(a) concentration during the stuidy period was considered to reflect a steady state in Lp(a) turnover. Fig. 2 shows a representative serum radioactivity time-curve. In all cases, the curves showed an initial rapid decline merging with a log-linear portion about 4 d after the injection of the labeled Lp(a). Since the radioactivity decay cturves could always be resolved into two exponentials by curve peeling (Fig. 2) , the kinetic parameters were calculated in terms of a two- The kinetic parameters of Lp(a) are presentedl cases the radioactivity time-curve was followed for in Table II . In subjects 7-9, the FCR wias also 21 d and the decay curves could also be resolved into calculated from the uirine/plasma radioactivity ratio. two exponientials. The kinetic paramiieters were This method can be applied for the estimation of Half-life of the first (bi) andI seconid (bh2) exponienitial of the serumiii radioactivity time-curve. 4 Valtues calculated from urinie/plassma radioactivity ratio, miiean-+ SD of the values from day 2 to 14. § Units for Lp(a) synthesis refer to the enitire Lp(a) miiolecuile. Lp(a) turnover, because practically all the radioactivity of the serum was contained in Lp(a) over the entire study period. The values obtained by this method were in close agreement with the values for FCR obtained from the die-away curve of the serum radioactivity (Table II) .
A positive correlation was found between the concentration of Lp(a) in the serum and the absolute rate of synthesis of serum Lp(a) apoproteins (Fig. 4) . There appeared to be a tendency toward an inverse relationship between the serum level of Lp(a) and FCR, but this correlation could not be proven statistically (Fig. 5) . No relationship existed between the serum concentration and half-lives of Lp(a) in the serum.
The mean FCR of Lp(a) was somewhat lower in the five subjects who received autologous Lp(a) as com-100 FIGuRE 5 Relationship between Lp(a) concentration in the serum and FCR of Lp(a).
After the intravenous injection of labeled Lp(a) only insignificant amounts of radioactivity were detectable in lipoproteins other than Lp(a) during the study period. The specific activity time-curves for the isolated whole Lp(a) molecule, the soluble and the insoluble Lp(a) apolipoproteins, and the radioactivity time-curve of the serum were identical. Apparently, Lp(a) is not converted to another lipoprotein and no exchange of apolipoproteins between Lp(a) and other lipoproteins takes place. Lp(a) appears to leave the plasma pool as an intact particle as suggested in a recent study (16) . Other experiments, in which labeled VLDL has been injected to Lp(a)-positive individuals, have shown that Lp(a) is not derived from the catabolism of other apolipoprotein B-containing lipoproteins (17) . Therefore, it is suggested that Lp(a) is synthesized and metabolized independently of other plasma lipoproteins. This conclusion could explain the findings of others that the serum level of Lp(a) is not influenced by various dietary manipulations that are known to cause considerable changes in the plasma concentrations of other lipoproteins (13) .
The half-life of Lp(a) has already been estimated using reductive alkylation as method of labeling (16) . Due to the low radioactivity of Lp(a) in this former study, the radioactivity time-curve of Lp(a) could be followed for only 4 d. Therefore, only the initial rapid decline of the whole die-away curve could be observed and hence a monoexponential plasma decay of Lp(a) was assumed (16) are not only immunological and chemical similarities between LDL and Lp(a). From the comparison of the kinetic parameters of these two lipoproteins one may suggest that these two lipoproteins also appear to be acted uipon by similar catabolic mechanisms. To prove this assumption kinetic studies of LDL and Lp(a) in patients with familiar hypercholesterolemia would be of interest.
It has been reported by others that the concentrations of Lp(a) vary in a wide range among the individuals of a population (13, 18, 35) . The Lp(a) level in a single individual, however, remains remarkably constant (13, 18) . Principally, the concentration of Lp(a) in the serum is dependent on the rate of synthesis and the FCR of the lipoprotein. The individuals in this study also showed very different serum Lp(a) levels. Their FCR, however, varied to a much lesser degree and there was no relationship between the concentration and FCR of Lp(a). On the other hand, a highly significant correlation was fouind between the serum concentration and the absolute synthetic rate of Lp(a). Therefore, it is concluded that the mechanism that is responsible for an elevated concentration of Lp(a) in the serum of these subjects is not a defective catabolism but an increased synthesis of Lp(a). It should be stated that the sttudies of this paper were performed in males. Until now no information is available on the Lp(a) turnover in females.
Studies with 1251-labeled LDL in patients with an elevated LDL concentration indicated a defect of LDL catabolism in these subjects. In homozygote and heterozygote patients with familial hyperbetalipoproteinemia, a reduced FCR of LDL was found (31) (32) (33) (34) . A marked increase in the synthesis of LDL in the homozygotes has also been reported (32) . In this study, the Lp(a) concentrationi was not dependent oni the FCR of Lp(a). However, the possibility that a defective catabolism, as found in familial hyperbetalipoproteinemia, is responsible for an increased Lp(a) level cannot be excluded. Until now, no information is available about the site and regulation of Lp(a) synthesis or catabolism.
